From conclave to collaboration – Team CLINEXEL is ready to drive vaccine innovation forward.

India Vaccine Leaders Conclave brought together industry experts to discuss the future of vaccine innovation, clinical development, and public health. India is the largest supplier of vaccines globally, contributing nearly 70% of the world’s vaccine supply and holding a significant number of WHO-prequalified vaccines.

Yet, what we truly need are innovative vaccines for diseases that continue to cause high morbidity and mortality in India, such as:

• Dengue
• Malaria
• Tuberculosis

Developing these requires:

• Strong science
• Efficient clinical development & operations
• Deep understanding of Indian & global regulations

At CLINEXEL, we are delighted to have participated in the India Vaccine Leaders Conclave and are committed to supporting the development of next-generation vaccines through our expertise in clinical trials and clinical development, both in India and globally.

We look forward to meaningful collaborations that drive innovation and improve public health outcomes. Write to us at info@clinexel.com for our clinical research and clinical development services.